2-((5-(4-fluorobenzyl)-7-oxo-2H-[1,2,3]triazolo[4,5-d]pyrimidin-3(7H)-yl)methylthio)-N-(3-methoxyphenyl)acetamide

ID: ALA4574490

Chembl Id: CHEMBL4574490

Max Phase: Preclinical

Molecular Formula: C21H19FN6O3S

Molecular Weight: 454.49

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cccc(NC(=O)CSCn2[nH]nc3c(=O)nc(Cc4ccc(F)cc4)nc2-3)c1

Standard InChI:  InChI=1S/C21H19FN6O3S/c1-31-16-4-2-3-15(10-16)23-18(29)11-32-12-28-20-19(26-27-28)21(30)25-17(24-20)9-13-5-7-14(22)8-6-13/h2-8,10,27H,9,11-12H2,1H3,(H,23,29)

Standard InChI Key:  FBEUVZPMDGJVRC-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4574490

    ---

Associated Targets(Human)

UCK2 Tbio Uridine-cytidine kinase 2 (58 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 454.49Molecular Weight (Monoisotopic): 454.1223AlogP: 2.53#Rotatable Bonds: 8
Polar Surface Area: 114.79Molecular Species: ACIDHBA: 8HBD: 2
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 4.35CX Basic pKa: CX LogP: 1.97CX LogD: 1.37
Aromatic Rings: 2Heavy Atoms: 32QED Weighted: 0.42Np Likeness Score: -1.70

References

1. Okesli-Armlovich A, Gupta A, Jimenez M, Auld D, Liu Q, Bassik MC, Khosla C..  (2019)  Discovery of small molecule inhibitors of human uridine-cytidine kinase 2 by high-throughput screening.,  29  (18): [PMID:31420268] [10.1016/j.bmcl.2019.08.010]

Source